Chiesi UK Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Chiesi UK's estimated annual revenue is currently $58.9M per year.(i)
  • Chiesi UK's estimated revenue per employee is $201,000

Employee Data

  • Chiesi UK has 293 Employees.(i)
  • Chiesi UK grew their employee count by 6% last year.

Chiesi UK's People

NameTitleEmail/Phone
1
Head DepartmentReveal Email/Phone
2
Head SalesReveal Email/Phone
3
Head New Business DevelopmentReveal Email/Phone
4
Head Market AccessReveal Email/Phone
5
PV OfficerReveal Email/Phone
6
Head Supply ChainReveal Email/Phone
7
Pharmacovgilance OfficerReveal Email/Phone
8
Head External CommunicationsReveal Email/Phone
9
Head Marketing Special CareReveal Email/Phone
10
Data ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Chiesi UK?

Chiesi is an international, privately-owned pharmaceutical company, with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the field of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 4,100 people in 26 affiliates worldwide and sells its products in more than 70 countries. In the UK, Chiesi Ltd. employs c.250 dedicated employees, who are based out of our new head office in Manchester, the Research and Development centre in the South of England, or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability, in everything we do. It emphasises the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. As we enter important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions, Chiesi Ltd. is poised to extend further still the contribution we make to public health in the UK. As the winners of an independent Top Employer Award in the UK and Europe for the sixth consecutive year, ours is a culture where innovation and professional excellence flourish.

keywords:N/A

N/A

Total Funding

293

Number of Employees

$58.9M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Chiesi UK News

2022-04-06 - Chiesi Group Continues to Grow In 2021

Europe remains Chiesi's biggest market, representing 72% of turnover, of which 18% comes from the UK (UK 18%; Germany 13%; Italy 11%; other...

2022-03-22 - CHIESI GROUP CONTINUES GROWTH

Europe remains Chiesi's biggest market, representing 72% of turnover (UK 18%; Germany 13%; Italy 11%; other European markets 31%), followed by...

2022-03-22 - Orbia's Koura Business opens world's first HFA 152a medical ...

... and supply of fluoroproducts and technologies, today opens a new HFA 152a production facility at their Runcorn site in the UK. Chiesi...

2019-09-08 - Bronchopulmonary Dysplasia Treatment Market Growth and Status Explored in a New Research Report: Chiesi Farmaceutici, Meridigen Biotech, Therabron Therapeutics, etc

Chiesi Farmaceutici, Meridigen Biotech, Therabron Therapeutics, Airway Therapeutics, ... Europe (Germany, France, UK, Russia, and Italy)

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$87.6M29511%N/A
#2
$66M297-15%N/A
#3
$107.5M29810%N/A
#4
$72.6M300-22%N/A
#5
$47.9M30052%N/A